Cancer drug ruling: It is triumph of human values, says Natco Director

The IPAB ruling in favour of the Natco Pharma against Bayer has reignited the debate over innovation versus access in the health sector.

Govt allows Natco to sell Bayer-patented cancer drug

India today invoked a WTO provision and permitted Hyderabad-based Natco Pharma to manufacture and sell cancer-treatment drug Nexavar.

Govt allows Natco to sell Bayer-patented cancer drug

India today invoked a WTO provision and permitted Hyderabad-based Natco Pharma to manufacture and sell cancer-treatment drug Nexavar.